» Articles » PMID: 110689

Effect of Type-specific Active Immunization on the Development and Progression of Experimental Pseudomonas Aeruginosa Endocarditis

Overview
Journal Infect Immun
Date 1979 Apr 1
PMID 110689
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Rabbits with intracardiac catheters were immunized with heat-killed Pseudomonas aeruginosa or saline and challenged with either 10(9) (high inoculum) or 10(7) (low inoculum) pseudomonas. Immunization did not decrease the incidence of endocarditis when compared with controls, but it did significantly prolong survival. The longer survival of immunized rabbits after high-inoculum challenge was not due to prolongation of the course of endocarditis but to type-specific protection from early, overwhelming bacteremia. However, after low-inoculum challenge there were no early deaths and there was a significantly (P < 0.01) longer survival of immunized (17.4 days) than unimmunized (10.6 days) animals dying of endocarditis. Increased survival was associated with higher total and 2-mercaptoethanol-resistant hemagglutinating antibody titers 1 week after challenge in immunized as compared with unimmunized rabbits. Early (48 h after challenge) vegetation colonization was also significantly (P < 0.05) greater after type-specific as opposed to non-type-specific or saline immunization and low-inoculum challenge. However, whereas 67% of type-specifically immunized rabbits had colonized vegetations at 48 h, only 38.9% died with bacteremic endocarditis. Another 19.2% of immunized rabbits had vegetations colonized with > 10(5) colony-forming units of pseudomonas at elective sacrifice 2 weeks after challenge but no bacteremia; no unimmunized rabbit exhibited similar late colonization. Preexisting antibody may be important in the pathogenesis of pseudomonas endocarditis in drug addicts, and its presence may explain the subacute and often protracted course of the disease.

Citing Articles

Antibodies to a surface-exposed, N-terminal domain of aggregation substance are not protective in the rabbit model of Enterococcus faecalis infective endocarditis.

McCormick J, Hirt H, Waters C, Tripp T, Dunny G, Schlievert P Infect Immun. 2001; 69(5):3305-14.

PMID: 11292753 PMC: 98289. DOI: 10.1128/IAI.69.5.3305-3314.2001.


Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats.

Viscount H, Munro C, Peterson D, Macrina F Infect Immun. 1997; 65(3):994-1002.

PMID: 9038308 PMC: 175080. DOI: 10.1128/IAI.65.3.994-1002.1997.


Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.

Nemeth J, Lee J Infect Immun. 1995; 63(2):375-80.

PMID: 7821999 PMC: 173005. DOI: 10.1128/iai.63.2.375-380.1995.


Effect of immunization on the genesis of pneumococcal endocarditis in rabbits.

Adler 2nd S, Selinger D, REED W Infect Immun. 1981; 34(1):55-61.

PMID: 7298192 PMC: 350820. DOI: 10.1128/iai.34.1.55-61.1981.


Effects of immunization and anticoagulation on the development of experimental Escherichia coli endocarditis.

Thorig L, Thompson J, Van Furth R Infect Immun. 1980; 28(2):325-30.

PMID: 6995305 PMC: 550937. DOI: 10.1128/iai.28.2.325-330.1980.


References
1.
McGeown M . Bacterial endocarditis; an experimental study of healing. J Pathol Bacteriol. 1954; 67(1):179-86. DOI: 10.1002/path.1700670122. View

2.
Feller I, VIAL A, Callahan W, WALDYKE J . USE OF VACCINE AND HYPERIMMUNE SERUM FOR PROTECTION AGAINST PSEUDOMONAS SEPTICEMIA. J Trauma. 1964; 4:451-6. DOI: 10.1097/00005373-196407000-00002. View

3.
Reyes M, Fisher M, Lerner A . Pseudomonas endocarditis: hemagglutinating antibodies to Fisher-Devlin-Gnabasik immunotypes in sera. J Lab Clin Med. 1974; 83(6):845-52. View

4.
Archer G, Fekety F, Supena R . Pseudomonas aeruginosa endocarditis in drug addicts. Am Heart J. 1974; 88(5):570-8. DOI: 10.1016/0002-8703(74)90240-3. View

5.
Crowder J, Devlin H, Fisher M, White A . Heat-stable opsonins in sera of patients with Pseudomonas infections. J Lab Clin Med. 1974; 83(6):853-9. View